Posted by Michael Wonder on 30 Nov 2017
Schedule of Pharmaceutical Benefits - 1 December 2017 update
1 December 2017 - The December 2017 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The December issue of the Schedule includes a number of minor new/revised listings:
- Abiraterone acetate (Zytiga) - new strength
- Eribulin mesylate (Halaven) - new indication
- Etanercept (Brenzys) - restriction change
- Ibrutinib (Imbruvica) - new medicine
- Mesalazine (Azacol) - new strength
- Milk powder - lactose intolerance formula (S-26 Original Li) - new formulation
- Vitamins, minerals and trace elements formula (Phlexy Vits) - new combination product
Read Summary of Changes
Posted by:
Michael Wonder